Tags

Type your tag names separated by a space and hit enter

Synthetic human calcitonin in refractory Paget's disease of bone.
Arch Intern Med. 1987 Jul; 147(7):1305-8.AI

Abstract

Fourteen patients with symptomatic and active Paget's disease of bone who had demonstrated resistance to parenteral synthetic salmon calcitonin, oral disodium etidronate, or both in combination were treated with parenteral synthetic human calcitonin. Eleven patients (79%) demonstrated clinical and chemical improvement for up to five years. Two patients received additional benefit with combined synthetic human calcitonin and etidronate disodium.

Authors

No affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

3111398

Citation

Altman, R D., and B Collins-Yudiskas. "Synthetic Human Calcitonin in Refractory Paget's Disease of Bone." Archives of Internal Medicine, vol. 147, no. 7, 1987, pp. 1305-8.
Altman RD, Collins-Yudiskas B. Synthetic human calcitonin in refractory Paget's disease of bone. Arch Intern Med. 1987;147(7):1305-8.
Altman, R. D., & Collins-Yudiskas, B. (1987). Synthetic human calcitonin in refractory Paget's disease of bone. Archives of Internal Medicine, 147(7), 1305-8.
Altman RD, Collins-Yudiskas B. Synthetic Human Calcitonin in Refractory Paget's Disease of Bone. Arch Intern Med. 1987;147(7):1305-8. PubMed PMID: 3111398.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Synthetic human calcitonin in refractory Paget's disease of bone. AU - Altman,R D, AU - Collins-Yudiskas,B, PY - 1987/7/1/pubmed PY - 1987/7/1/medline PY - 1987/7/1/entrez SP - 1305 EP - 8 JF - Archives of internal medicine JO - Arch Intern Med VL - 147 IS - 7 N2 - Fourteen patients with symptomatic and active Paget's disease of bone who had demonstrated resistance to parenteral synthetic salmon calcitonin, oral disodium etidronate, or both in combination were treated with parenteral synthetic human calcitonin. Eleven patients (79%) demonstrated clinical and chemical improvement for up to five years. Two patients received additional benefit with combined synthetic human calcitonin and etidronate disodium. SN - 0003-9926 UR - https://www.unboundmedicine.com/medline/citation/3111398/Synthetic_human_calcitonin_in_refractory_Paget's_disease_of_bone_ L2 - https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/vol/147/pg/1305 DB - PRIME DP - Unbound Medicine ER -